Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy

Stopped Due to the rarity and rapid progressive course of the disease, patients were less likely to participate in randomization.

Conditions

• Glomerulonephritis, IGA
• Kidney Diseases
• Acute Renal Insufficiency
• Rapidly Progressive Glomerulonephritis

Interventions

• PROCEDURE: Plasma Exchange (PE)
• DRUG: Methylprednisolone pulse

Sponsor

Peking University First Hospital